Biotargets of Cancer in Current Clinical Practice

Author:   Mauro Bologna
Publisher:   Humana Press Inc.
Edition:   2012
ISBN:  

9781617796142


Pages:   564
Publication Date:   05 April 2012
Format:   Hardback
Availability:   Not yet available   Availability explained
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.

Our Price $630.96 Quantity:  
Add to Cart

Share |

Biotargets of Cancer in Current Clinical Practice


Add your own review!

Overview

Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.

Full Product Details

Author:   Mauro Bologna
Publisher:   Humana Press Inc.
Imprint:   Humana Press Inc.
Edition:   2012
Dimensions:   Width: 17.80cm , Height: 3.60cm , Length: 25.40cm
Weight:   1.273kg
ISBN:  

9781617796142


ISBN 10:   161779614
Pages:   564
Publication Date:   05 April 2012
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Not yet available   Availability explained
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.

Table of Contents

Central Nervous System Tumors.- Head and Neck Tumors.- Thyroid Cancer.- Targeted Therapies for Non-Small Cell Lung Cancer.- Non-Hodgkin Lymphomas.- Leukemias.- Breast Cancer.- Esophago-Gastric Cancer.- Colorectal Cancer.- Hepatocellular Carcinoma.- Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma.- Bladder Cancer.- Biomarkers in Prostate cancer.- Ovarian Cancer.- Uterine Cancer: The Influence of Genetics and Environment on Cell Cycling Pathways in Cancer.- Biotargets in Sarcomas: The Past, Present and a Look into the Future.- Melanoma and other skin cancers.- Molecular pathology of cancer metastasis: suggestions for future therapy.- Current and future developments in cancer therapy research: miRNAs as new promising targets or tools.

Reviews

From the reviews: “In this book on clinically significant biotargets in cancer research, every organ system is thoroughly represented with adequate overviews and precise details of the biotargets. … the book is intended specifically for clinicians in the field, including medical students, residents, pathologists, and oncologists. … This is a well-written book that attempts to provide a wide spectrum of current scientific information about the clinical management of oncologic patients based on molecular aspects. … this book achieves its objectives while remaining easy to read.” (Natalie Webster, Doody’s Review Service, October, 2012)


From the reviews: In this book on clinically significant biotargets in cancer research, every organ system is thoroughly represented with adequate overviews and precise details of the biotargets. ... the book is intended specifically for clinicians in the field, including medical students, residents, pathologists, and oncologists. ... This is a well-written book that attempts to provide a wide spectrum of current scientific information about the clinical management of oncologic patients based on molecular aspects. ... this book achieves its objectives while remaining easy to read. (Natalie Webster, Doody's Review Service, October, 2012)


From the reviews: In this book on clinically significant biotargets in cancer research, every organ system is thoroughly represented with adequate overviews and precise details of the biotargets. ... the book is intended specifically for clinicians in the field, including medical students, residents, pathologists, and oncologists. ... This is a well-written book that attempts to provide a wide spectrum of current scientific information about the clinical management of oncologic patients based on molecular aspects. ... this book achieves its objectives while remaining easy to read. (Natalie Webster, Doody's Review Service, October, 2012)


Author Information

Mauro Bologna, MD University of L’Aquila, L’Aquila, Italy

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List